Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Jaeger

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Neurology|March 6, 2021
Value-Generating Exploratory Trials in Neurodegenerative DementiasLauren G Friedman, Nicholas McKeehan, Yuko Hara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2021
Diagnostic criteria for apathy in neurocognitive disordersDavid S Miller, Philippe Robert, Larry Ereshefsky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Neurology|March 6, 2021
Value-Generating Exploratory Trials in Neurodegenerative DementiasLauren G Friedman, Nicholas McKeehan, Yuko Hara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 5, 2021
Diagnostic criteria for apathy in neurocognitive disordersDavid S Miller, Philippe Robert, Larry Ereshefsky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Pageof 7